This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Shanmugarajan, S. Articles by Reddy, S. V. Search for Related Content PubMed PubMed Citation Articles by Shanmugarajan, S. Articles by Reddy, S. V. Social Bookmarking                         What's this?

Congenital Bone Fractures in Spinal Muscular Atrophy: Functional Role for SMN Protein in Bone Remodeling

Charles P. Darby Children's Research Institute, Medical University of South Carolina, Charleston

Kathryn J. Swoboda, MD

Department of Neurology, University of Utah School of Medicine, Salt Lake City

Susan T. Iannaccone, MD, FAAN

Department of Child Neurology, Children's Medical Center, University of Texas Southwestern Medical Center, Dallas

William L. Ries, DDS, PhD

Charles P. Darby Children's Research Institute, Medical University of South Carolina, Charleston

Bernard L. Maria, MD, MBA

Charles P. Darby Children's Research Institute, Medical University of South Carolina, Charleston

Sakamuri V. Reddy, PhD

Charles P. Darby Children's Research Institute, Medical University of South Carolina, Charleston, reddysv{at}musc.edu

Spinal muscular atrophy is the second most common fatal childhood disorder. Core clinical features include muscle weakness caused by degenerating lower motor neurons and a high incidence of bone fractures and hypercalcemia. Fractures further compromise quality of life by progression of joint contractures or additional loss of motor function. Recent observations suggest that bone disease in spinal muscular atrophy may not be attributed entirely to lower motor neuron degeneration. The presence of the spinal muscular atrophy disease-determining survival motor neuron gene (SMN), SMN expression, and differential splicing in bone-resorbing osteoclasts was recently discovered. Its ubiquitous expression and the differential expression of splice variants suggest that SMN has specific roles in bone cell function. SMN protein also interacts with osteoclast stimulatory factor. Mouse models of human spinal muscular atrophy disease suggest a potential role of SMN protein in skeletal development. Dual energy x-ray absorptiometry analysis demonstrated a substantial decrease in total bone area and poorly developed caudal vertebra in the mouse model. These mice also had pelvic bone fractures. Studies delineating SMN signaling mechanisms and gene transcription in a cell-specific manner will provide important molecular insights into the pathogenesis of bone disease in children with spinal muscular atrophy. Moreover, understanding bone remodeling in spinal muscular atrophy may lead to novel therapeutic approaches to enhance skeletal health and quality of life. This article reviews the skeletal complications associated with spinal muscular atrophy and describes a functional role for SMN protein in osteoclast development and bone resorption activity.

Key Words: spinal muscular atrophy • bone fractures • SMN protein • osteoclasts

Journal of Child Neurology, Vol. 22, No. 8, 967-973 (2007)
DOI: 10.1177/0883073807305664


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. A. Brumback Child Neurologists Should Be Interested In Brain Tumors! J Child Neurol, November 1, 2009; 24(11): 1338 - 1340. [PDF]